Endevica Bio Alternatives & Competitors
12 companies similar to Endevica Bio — Reversing cachexia and improving quality of life in cancer patients. Phase 1 tri...
Companies similar to Endevica Bio
BBB Therapeutics
Combines existing drugs with it's proprietary for enhanced drug delivery across the blood-...
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
TransPharma Medical
Pioneering transdermal drug delivery to enhance therapeutic outcomes for osteoporosis and...
Agennix
Crafting novel therapies to enhance the length and quality of life for seriously ill patie...
Track all Endevica Bio competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Lumos Pharma
Transforming Lives with Rare Focus
Atorvia Health Technologies
Fearlessly tackling kidney failure
Centrexion Therapeutics Corp.
We aim to relieve the suffering associated with chronic pain by creating treatments that a...
Taiga Biotechnologies
Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the...
Pulmatrix Inc.
Changing medicine with a new generation of pulmonary-delivered therapeutics
Allena Pharmaceuticals, Inc.
Developing Therapeutics for Patients with Rare and Severe Metabolic and Kidney Disorders
About Endevica Bio
Endevica Bio, founded in 2009, is making strides in the Biotechnology and Pharmaceutical industries with a focus on addressing health and wellness. The company is headquartered in the United States. The startup's mission, encapsulated in their slogan, “Reversing cachexia and improving quality of life in cancer patients...
Development of peptide-based therapies, Conducting Phase 2 trials for oncology and metabolic disorders, Research and development in novel peptidomimetics, Providing science-driven solutions in medicine
Healthcare providers, Oncologists, Metabolic disorder specialists, Pharmaceutical companies, Patients affected by cancer cachexia and obesity
Endevica Bio, Peptide Therapeutic, Cancer Cachexia, Phase 1 Clinical Trials, Clinical-stage Biopharmaceutical Company, Peptide Drug Candidates, Drug Safety, Efficacy Properties, Technology Platform, Patented Technology, Peptide Modification, Half-life Improvement, Oral Activity, Blood-brain Barrier, Drug Development
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Endevica Bio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Endevica Bio on 12 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.